Connor, Clark & Lunn Investment Management (CC&L)’s Q32 Bio QTTB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-645
| Closed | -$13.6K | – | 1591 |
|
2023
Q3 | $13.6K | Sell |
645
-4,500
| -87% | -$94.8K | ﹤0.01% | 1331 |
|
2023
Q2 | $82K | Sell |
5,145
-4,420
| -46% | -$70.4K | ﹤0.01% | 1253 |
|
2023
Q1 | $177K | Sell |
9,565
-1,378
| -13% | -$25.5K | ﹤0.01% | 1112 |
|
2022
Q4 | $248K | Sell |
10,943
-1,990
| -15% | -$45.1K | ﹤0.01% | 1009 |
|
2022
Q3 | $375K | Buy |
12,933
+311
| +2% | +$9.02K | ﹤0.01% | 875 |
|
2022
Q2 | $448K | Buy |
12,622
+1,738
| +16% | +$61.7K | ﹤0.01% | 807 |
|
2022
Q1 | $596K | Sell |
10,884
-425
| -4% | -$23.3K | ﹤0.01% | 755 |
|
2021
Q4 | $741K | Buy |
11,309
+5,093
| +82% | +$334K | ﹤0.01% | 724 |
|
2021
Q3 | $880K | Buy |
6,216
+1,572
| +34% | +$223K | ﹤0.01% | 669 |
|
2021
Q2 | $608K | Buy |
+4,644
| New | +$608K | ﹤0.01% | 754 |
|